Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients
Clinical trial NCT04304352 · UNKNOWN
Trial details
- NCT number
- NCT04304352
- Sponsor
- European Institute of Oncology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-29
- Primary completion
- 2023-12-31
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.